ArticleBioPsychoSocial medicine2026
Validation of the Japanese version of the death and dying distress scale.
Article in BioPsychoSocial medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe Death and Dying Distress Scale (DADDS) is a self-report instrument used to assess distress related to dying and death in patients with advanced cancer. We aimed to test the reliability and validity of the Japanese-translated version of the DADDS (DADDS-J) and evaluate its psychological properties in patients with advanced cancer in Japan.
methodsJapanese participants with advanced cancer (n = 200) completed the DADDS and additional tools measuring depression (Patient Health Questionnaire-9), anxiety (Generalized Anxiety Disorder-7), quality of life (Functional Assessment of Cancer Therapy-General; Japanese Version of the Quality of Life at the End of Life-Cancer Scale), symptom burden (Japanese Version of the Quality of Life at the End of Life-Cancer Scale), and spirituality (Functional Assessment of Chronic Illness Therapy-Spiritual Well-Being). Exploratory factor analysis (EFA), parallel analysis, and confirmatory factor analyses (CFA) were performed on 15 DADDS items. Internal consistency was assessed using Cronbach's alpha and McDonald's ω, and construct validity was examined by calculating correlations with relevant scales.
resultsEFA and parallel analysis identified a three-factor structure in the 14-item DADDS-J after item 3 was excluded, with Cronbach's alpha and McDonald's ω ranging from 0.85 to 0.92. CFA showed an adequate fit for the unique structure. Each subscale was significantly correlated with age, depression, anxiety, symptom burden, and lower quality of life and spirituality, but not with social and family well-being or time since cancer diagnosis.
conclusionsThe DADDS-J has a three-factor structure and demonstrates good reliability and validity. Differences between the original and Japanese versions of the scale may be due to cultural factors. This is the first tool that can measure spiritual pain associated with death in patients with advanced cancer in Japan and is suitable for large-scale studies and clinic use. This scale can enhance research and clinical care for patients with advanced cancer in Japan.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.